Sept 7 (Reuters) - Biotron Ltd BIT.AX :
* ANNOUNCES CONCLUSION OF FIRST STAGE OF SCREENING SELECTED BIOTRON COMPOUNDS AGAINST SARS-COV-2
* SEVERAL COMPOUNDS HAVE BEEN SHOWN IN LABORATORY CELL-CULTURE STUDIES TO HAVE ANTIVIRAL ACTIVITY AGAINST SARS- COV-2 Source ( https:// Further company coverage: BIT.AX